These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17332242)

  • 21. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.
    Hartmann EM; Campo E; Wright G; Lenz G; Salaverria I; Jares P; Xiao W; Braziel RM; Rimsza LM; Chan WC; Weisenburger DD; Delabie J; Jaffe ES; Gascoyne RD; Dave SS; Mueller-Hermelink HK; Staudt LM; Ott G; Beà S; Rosenwald A
    Blood; 2010 Aug; 116(6):953-61. PubMed ID: 20421449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
    Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
    Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
    De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
    Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research advance of p53 gene in mantle cell lymphoma].
    Zhou LT; Zhu JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):835-8. PubMed ID: 21729583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades.
    Swerdlow SH; Williams ME
    Hum Pathol; 2002 Jan; 33(1):7-20. PubMed ID: 11823969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine CGA codons as a source of nonsense mutations: a possible role in multivariant gene expression, control of mRNA quality, and aging.
    Romanov GA; Sukhoverov VS
    Mol Genet Genomics; 2017 Oct; 292(5):1013-1026. PubMed ID: 28523359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas.
    Tort F; Hernàndez S; Beà S; Martínez A; Esteller M; Herman JG; Puig X; Camacho E; Sánchez M; Nayach I; Lopez-Guillermo A; Fernández PL; Colomer D; Hernàndez L; Campo E
    Blood; 2002 Dec; 100(13):4602-8. PubMed ID: 12393693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsense mutation-dependent reinitiation of translation in mammalian cells.
    Cohen S; Kramarski L; Levi S; Deshe N; Ben David O; Arbely E
    Nucleic Acids Res; 2019 Jul; 47(12):6330-6338. PubMed ID: 31045216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
    de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP
    Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unbalanced expression of licensing DNA replication factors occurs in a subset of mantle cell lymphomas with genomic instability.
    Pinyol M; Salaverria I; Bea S; Fernández V; Colomo L; Campo E; Jares P
    Int J Cancer; 2006 Dec; 119(12):2768-74. PubMed ID: 17036332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Aurora-A and hMPS1 mitotic kinases in mantle cell lymphoma.
    Camacho E; Beà S; Salaverría I; López-Guillermo A; Puig X; Benavente Y; de Sanjosé S; Campo E; Hernández L
    Int J Cancer; 2006 Jan; 118(2):357-63. PubMed ID: 16080195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
    Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of disease phenotype through alternative translation initiation in low-penetrance retinoblastoma.
    Sánchez-Sánchez F; Ramírez-Castillejo C; Weekes DB; Beneyto M; Prieto F; Nájera C; Mittnacht S
    Hum Mutat; 2007 Feb; 28(2):159-67. PubMed ID: 16988938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
    Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
    Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
    Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
    Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells.
    Lu K; Chen N; Zhou XX; Ge XL; Feng LL; Li PP; Li XY; Geng LY; Wang X
    Biochem Biophys Res Commun; 2015 Aug; 464(1):292-8. PubMed ID: 26116769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition.
    Noensie EN; Dietz HC
    Nat Biotechnol; 2001 May; 19(5):434-9. PubMed ID: 11329012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?
    Anczuków O; Ware MD; Buisson M; Zetoune AB; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S
    Hum Mutat; 2008 Jan; 29(1):65-73. PubMed ID: 17694537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model.
    M'kacher R; Farace F; Bennaceur-Griscelli A; Violot D; Clausse B; Dossou J; Valent A; Parmentier C; Ribrag V; Bosq J; Carde P; Turhan AG; Bernheim A
    Cancer Genet Cytogenet; 2003 May; 143(1):32-8. PubMed ID: 12742154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.
    Schraders M; Jares P; Bea S; Schoenmakers EF; van Krieken JH; Campo E; Groenen PJ
    Br J Haematol; 2008 Oct; 143(2):210-21. PubMed ID: 18699851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.